US FDA bans unapproved ophthalmic and papain products
This article was originally published in Scrip
Executive Summary
The US FDAhas moved to ban manufacturing and sale of unapproved ophthalmic balanced salt solutions and topical papain products for safety reasons. Such products are deemed to be "new drugs" that require approved applications because they are not generally recognised as safe and effective.